Boehringer Ingelheim India has appointed Vani Manja as Managing Director and Head of Human Pharma, effective January 1, 2021. Vani succeeds Sharad Tyagi, who retired from Boehringer Ingelheim India on December 31, 2020, the company said.
In the role, Vani will assume responsibility for the company’s businesses in India, Bangladesh, Nepal and Sri Lanka. She will also join the board of the company, Boehringer Ingelheim said in a statement.
Commenting on the development, Thorsten Poehl, Boehringer Ingelheim Head of Emerging Markets, said: “India presents a unique opportunity for Boehringer Ingelheim, wherein we affirm our commitment to patients and people in the country with our products and services.”
Vani is a proven and respected leader who has a strong track record of leading complex transformations and delivering results, he added.
Most recently, Vani was the Global Head of Boehringer Ingelheim’s Go-To-Market and Business Steering organisation, based in the company’s headquarters in Germany.
She joined Boehringer Ingelheim in the US in 2011, working across strategy and operations, marketing and sales leadership roles before moving to Ingelheim in 2016 as Regional Business Manager for Japan, the statement said.
Vani holds an MBA and MA in International Studies from the Wharton School at the University of Pennsylvania in Philadelphia, and a Bachelor’s degree with Honors in Chemistry from Delhi University, it added.
